YTHDF2 is negatively correlated with survival in HCC patients and YTHDF2 upregulates octamer-binding transcription factor 4 (OCT4) expression in an m6A-dependent manner, promoting HCC progression (Zhang et al., 2020a). This evidence concerns the gene POU5F1 and hepatocellular carcinoma.